Ipratropium Bromide
Active substance: ipratropium
SOLUTION · IPRATROPIUM BROMIDE .5 mg/2.5mL
United StatesActive
Marketing holder: Mylan Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- IPRATROPIUM BROMIDE · .5 mg/2.5mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-774d-7a55-92e1-502b67f1f52e,01a1208c-a23b-76da-8287-c34fefeb4928,01a1208c-a896-7a4d-9fe4-d2c658056a7a,01a1208c-bbb3-712d-addd-a6e7feac78d0,01a1208c-ede1-7d17-b664-5f57dc53ba69;count=36 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0378-7970
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- RESPIRATORY (INHALATION)
Sources
- product · openFDA NDC · 0378-7970 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0378-7970 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0378-7970 · Verified 2026-10-09 · open in source